# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-020625
Filing Date
2023-06-09
Accepted
2023-06-08 18:49:03
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-ka.htm iXBRL | 10-K/A | 2030640
2 |  | ex23-3.htm | EX-23.3 | 4033
3 |  | ex23-4.htm | EX-23.4 | 4551
4 |  | ex31-3.htm | EX-31.3 | 12150
5 |  | ex31-4.htm | EX-31.4 | 12148
6 |  | ex32-2.htm | EX-32.2 | 9250
| Complete submission text file | 0001493152-23-020625.txt |  | 11371873

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | envb-20221231.xsd | EX-101.SCH | 76862
8 | XBRL CALCULATION FILE | envb-20221231_cal.xml | EX-101.CAL | 69050
9 | XBRL DEFINITION FILE | envb-20221231_def.xml | EX-101.DEF | 346868
10 | XBRL LABEL FILE | envb-20221231_lab.xml | EX-101.LAB | 646048
11 | XBRL PRESENTATION FILE | envb-20221231_pre.xml | EX-101.PRE | 501936
79 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-ka_htm.xml | XML | 2459458

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38286 | Film No.: 231003362
SIC: 2834 Pharmaceutical Preparations